TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
BICO Group AB Class B ( (SE:BICO) ) has shared an announcement.
BICO Group AB announced the release of its Q3 2025 interim report scheduled for November 4, 2025. Following the report’s publication, a telephone conference will be held to discuss the results, featuring presentations by the company’s President & CEO and CFO. This announcement reflects BICO’s commitment to transparency and engagement with stakeholders, providing insights into its financial performance and strategic direction.
The most recent analyst rating on (SE:BICO) stock is a Hold with a SEK36.00 price target. To see the full list of analyst forecasts on BICO Group AB Class B stock, see the SE:BICO Stock Forecast page.
More about BICO Group AB Class B
BICO Group AB is a lab automation partner and provider of selected workflows to the pharmaceutical and biotech industries. With over 48,000 instruments installed in more than 65 countries, their products and solutions are utilized in over 3,500 laboratories, including the world’s top 20 pharmaceutical companies. BICO operates through two business areas: Lab Automation and Life Science Solutions, aiming to enable and automate the life science lab of the future. The company is listed on Mid-Cap, Nasdaq Stockholm under BICO.
Average Trading Volume: 350,924
Technical Sentiment Signal: Sell
Current Market Cap: SEK1.59B
See more data about BICO stock on TipRanks’ Stock Analysis page.